TAFRO syndrome
Conditions
Interventions
None listed
Sponsors
Kanazawa Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with TAFRO syndrome or Japanese type of multicentric Castlman's disease.
Exclusion criteria
Exclusion criteria: malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Collection of clinical data and clinical course of patients with TAFRO syndrome. | — |
Secondary
| Measure | Time frame |
|---|---|
| Collection of clinical data and clinical course of patients with Japanese type of multicentric Castlman's disease. | — |
Countries
Japan
Contacts
Public ContactYasufumi Masaki
Kanazawa Medical University Hematology and Immunology
Outcome results
None listed